ArticleProceedings of the National Academy of Sciences of the United States of America2006

FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction.

Felix B Engel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.